Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has already received three other pivotal IDE approvals for its SCB MagicTouch […]

thaipr.net

30 พ.ค. 66

Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023

The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics (“Stemline”), a wholly-owned subsidiary of the Menarini Group, today announced results from a new analysis of the pivotal EMERALD clinical study that suggest that oral single-agent elacestrant may be effective in ER+, HER2- advanced or metastatic breast cancer patients with Non-Detected ESR1-mut […]

thaipr.net

29 พ.ค. 66

Nasdaq Deficiency Letter

On May 18, 2023, Etao International Co., Ltd. (the “Company”) received a deficiency letter from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it no longer complies with Nasdaq’s Listing Rule 5250(c)(1) due to its failure to file Form 20-F for the period ended December 31, 2022 (the “Filing”). Nasdaq informed the Company that […]

thaipr.net

29 พ.ค. 66

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up detection measures for hepatitis C (HCV) and hepatitis B (HBV), and for the early diagnosis and treatment of the viruses. Globally, more than 350 million people are living with viral hepatitis, and […]

thaipr.net

25 พ.ค. 66

ESOC 2023: AI tool outperforms human emergency call handlers in identifying stroke, new study shows

Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes and across all age groups studied, indicating its potential as a supplementary tool for early and precise stroke […]

thaipr.net

24 พ.ค. 66

CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech

CSafe, the largest provider of a complete range of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, is honored to announce an innovative program for Krystal Biotech that provides the cold chain solution for Krystal’s Vyjuvek gene therapy. CSafe’s custom thermal shipper for Krystal maintains -20°C throughout the product journey to help ensure that doses […]

thaipr.net

23 พ.ค. 66

Proem Behavioral Health and Dr. David V. Sheehan Issue Joint Statement

Proem Behavioral Health and Dr. David Sheehan have issued the following joint statement: “Nview Health, Inc., now known as Proem Behavioral Health, has exclusive rights to all Sheehan Technology in digital, electronic and pdf versions, except that Dr. Sheehan retains a right to license the paper format of the Sheehan Technology to third parties for distribution as follows: (1) in paper format for any uses; or (2) in fixed-pdf form, paper…

thaipr.net

23 พ.ค. 66

Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology

Waters™ Corporation (NYSE: WAT) today announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters’ ability to build a high-growth business in […]

thaipr.net

17 พ.ค. 66

Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that Snapdragon Chemistry has completed the second phase of its 51,000 square foot expansion in Waltham, Massachusetts. This expansion adds an additional 12,000 square feet to Snapdragon’s active pharmaceutical ingredient […]

thaipr.net

17 พ.ค. 66
1 11 12 13 14 15 73